Advertisement
Research Article

No Evidence for XMRV Nucleic Acids, Infectious Virus or Anti-XMRV Antibodies in Canadian Patients with Chronic Fatigue Syndrome

  • Imke Steffen,

    Affiliations: Blood Systems Research Institute, San Francisco, California, United States of America, Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America

    X
  • D. Lorne Tyrrell,

    Affiliation: Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada

    X
  • Eleanor Stein,

    Affiliation: Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada

    X
  • Leilani Montalvo,

    Affiliation: Blood Systems Research Institute, San Francisco, California, United States of America

    X
  • Tzong-Hae Lee,

    Affiliation: Blood Systems Research Institute, San Francisco, California, United States of America

    X
  • Yanchen Zhou,

    Affiliations: Blood Systems Research Institute, San Francisco, California, United States of America, Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America

    X
  • Kai Lu,

    Affiliation: Blood Systems Research Institute, San Francisco, California, United States of America

    X
  • William M. Switzer,

    Affiliation: Laboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Shaohua Tang,

    Affiliation: Laboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Hongwei Jia,

    Affiliation: Laboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Darren Hockman,

    Affiliation: Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada

    X
  • Deanna M. Santer,

    Affiliation: Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada

    X
  • Michael Logan,

    Affiliation: Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada

    X
  • Amir Landi,

    Affiliation: Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada

    X
  • John Law,

    Affiliation: Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada

    X
  • Michael Houghton mail,

    michael.houghton@ualberta.ca

    Affiliation: Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada

    X
  • Graham Simmons

    Affiliations: Blood Systems Research Institute, San Francisco, California, United States of America, Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America

    X
  • Published: November 17, 2011
  • DOI: 10.1371/journal.pone.0027870

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.